The combination of bulevirtide plus peginterferon alfa-2a is superior to bulevirtide monotherapy for achieving undetectable hepatitis D virus (HDV) RNA level at 24 weeks after the end of treatment in patients with chronic hepatitis D, according to a study published online June 6 in the New England Journal of Medicine to coincide with the annual congress of the European Association for the Study of the Liver, held from June 5 to 8 in Milan.
A Health Crisis Looms: Alarming Rise in Chronic Liver Disease Predicted by 2050 focustechnica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from focustechnica.com Daily Mail and Mail on Sunday newspapers.
National strategy to eliminate HCV must engage primary care providers to diagnose, treat healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
National survey data revealed a significant association between metabolic dysfunction-associated liver disease in patients aged 12-18 years and food insufficiency.